{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:54:39Z","timestamp":1790758479473,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1919,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003305","name":"ResMed Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSD\u2013Merck & Co."},{"name":"Menarini International Operations"},{"name":"Gedeon Richter Plc."},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company"},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol-Myers Squibb\u2013Pfizer Alliance"},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amgen Cardiovascular"},{"name":"Abbott Vascular International"},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003305","name":"ResMed Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial fibrillation (AF). The aim of the study is to assess the prevalence of AF, anticoagulation management, and risk of stroke\/transient ischaemic attack (TIA) in patients with cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Three thousand two hundred eight consecutive adult patients with cardiomyopathy (34.9% female; median age: 55.0 years) were prospectively enrolled as part of the EURObservational Research Programme Cardiomyopathy\/Myocarditis Registry. At baseline, 903 (28.2%) patients had AF (29.4% dilated, 27.5% hypertrophic, 51.5% restrictive, and 14.7% arrhythmogenic right ventricular cardiomyopathy, P &amp;lt; 0.001). AF was associated with more advanced New York Heart Association class (P &amp;lt; 0.001), increased prevalence of cardiovascular risk factors and co-morbidities, and a history of stroke\/TIA (P &amp;lt; 0.001). Oral anticoagulation was administered in 71.7% of patients with AF (vitamin K antagonist: 51.6%; direct oral anticoagulant: 20.1%). At 1 year follow-up, the incidence of cardiovascular endpoints was as follows: stroke\/TIA 1.85% (AF vs. non-AF: 3.17% vs. 1.19%, P &amp;lt; 0.001), death from any cause 3.43% (AF vs. non-AF: 5.39% vs. 2.50%, P &amp;lt; 0.001), and death from heart failure 1.67% (AF vs. non-AF: 2.44% vs. 1.31%, P = 0.033). The independent predictors for stroke\/TIA were as follows: AF [odds ratio (OR) 2.812, P = 0.005], history of stroke (OR 7.311, P = 0.010), and anaemia (OR 3.119, P = 0.006).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study reveals a high prevalence and diverse distribution of AF in patients with cardiomyopathies, inadequate anticoagulation regimen, and high risk of stroke\/TIA in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12854","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T08:51:47Z","timestamp":1600332707000},"page":"3601-3609","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Atrial Fibrillation, Anticoagulation Management and Risk of Stroke in the Cardiomyopathy\/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology"],"prefix":"10.1093","volume":"7","author":[{"given":"Katarzyna","family":"Mizia-Stec","sequence":"first","affiliation":[{"name":"First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia , 47 Zio\u0142owa St., Katowice, 40-635 ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida L.P.","family":"Caforio","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Cardiological Thoracic and Vascular Sciences and Public Health, University of Padua , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Cardiaques H\u00e9r\u00e9ditaires, Assistance Publique-H\u00f4pitaux de Paris, ICAN, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris ,","place":["France"]},{"name":"Sorbonne Universit\u00e9, INSERM UMR1166 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Gimeno","sequence":"additional","affiliation":[{"name":"Cardiac Department, Hospital Universitario Virgen de la Arrixaca , Murcia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Elliott","sequence":"additional","affiliation":[{"name":"Inherited Cardiac Diseases Unit, Barts Heart Centre, St Bartholomew's Hospital and University College London (UCL) , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Kaski","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology , Sophia Antipolis ,","place":["France"]},{"name":"ANMCO Research Center , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care and Research , Cotignola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos G.","family":"Rigopoulos","sequence":"additional","affiliation":[{"name":"Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle-Wittenberg , Halle ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology , Sophia Antipolis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Frigy","sequence":"additional","affiliation":[{"name":"Clinical County Hospital , T\u00e2rgu Mure\u0219 ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Zachara","sequence":"additional","affiliation":[{"name":"San Camillo Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Pena-Pena","sequence":"additional","affiliation":[{"name":"Cardiac Imaging and Inherited Cardiac Diseases Unit, Department of Cardiology, Virgen del Rocio University Hospital , Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinsanya","family":"Olusegun-Joseph","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos University Teaching Hospital , Lagos ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal","family":"Pinto","sequence":"additional","affiliation":[{"name":"Academic Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sala","sequence":"additional","affiliation":[{"name":"San Raffaele Hospital , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Drago","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Bambino Ges\u00f9 Children's Hospital and Research Institute , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Blagova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University) , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Reznik","sequence":"additional","affiliation":[{"name":"Russian National Research Medical University named after N.I. Pirogov , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Tendera","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Structural Heart Disease, School of Medicine in Katowice, Medical University of Silesia , Katowice ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"2026012114074666400_ehf212854-bib-0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0002","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026012114074666400_ehf212854-bib-0003","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0004","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet"},{"key":"2026012114074666400_ehf212854-bib-0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HCO.0b013e32832a1d2e","article-title":"Restrictive cardiomyopathy","volume":"24","author":"Mogensen","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"2026012114074666400_ehf212854-bib-0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012114074666400_ehf212854-bib-0007","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0008","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0009","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/europace\/euy064","article-title":"Atrial fibrillation in patients with inherited cardiomyopathies","volume":"21","author":"Yeung","year":"2019","journal-title":"Europace"},{"key":"2026012114074666400_ehf212854-bib-0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","article-title":"Frequency and phenotypes of familial dilated cardiomyopathy","volume":"31","author":"Grunig","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026012114074666400_ehf212854-bib-0012","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2004.06.024","article-title":"Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Losi","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026012114074666400_ehf212854-bib-0013","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026012114074666400_ehf212854-bib-0014","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjcard.2010.04.031","article-title":"Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and ventricular tachycardia","volume":"106","author":"Chu","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026012114074666400_ehf212854-bib-0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/heartjnl-2016-309672","article-title":"Predictors of atrial fibrillation in hypertrophic cardiomyopathy","volume":"103","author":"Guttmann","year":"2017","journal-title":"Heart"},{"key":"2026012114074666400_ehf212854-bib-0016","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2018.05.034","article-title":"Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry","volume":"271","author":"Boriani","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026012114074666400_ehf212854-bib-0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2017.08.011","article-title":"International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries","volume":"194","author":"Steinberg","year":"2017","journal-title":"Am Heart J"},{"key":"2026012114074666400_ehf212854-bib-0018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/eurheartj\/ehx730","article-title":"Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry","volume":"39","author":"Verheugt","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0019","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF","volume":"37","author":"Bassand","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114074666400_ehf212854-bib-0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"2026012114074666400_ehf212854-bib-0021","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0038-1676818","article-title":"Hypertrophic cardiomyopathy in patients with atrial fibrillation: prevalence and associated stroke risks in a nationwide cohort study","volume":"119","author":"Jung","year":"2019","journal-title":"Thromb Haemost"},{"key":"2026012114074666400_ehf212854-bib-0022","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.117.031743","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: new light on an old problem","volume":"136","author":"Spirito","year":"2017","journal-title":"Circulation"},{"key":"2026012114074666400_ehf212854-bib-0023","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"2026012114074666400_ehf212854-bib-0024","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15420\/aer.2017:4:2","article-title":"Atrial fibrillation and anticoagulation in hypertrophic cardiomyopathy","volume":"6","author":"Camm","year":"2017","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2026012114074666400_ehf212854-bib-0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/2013.jamainternmed.744","article-title":"Atrial fibrillation and the risk of sudden cardiac death: the Atherosclerosis Risk in Communities Study and Cardiovascular Health Study","volume":"173","author":"Chen","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2026012114074666400_ehf212854-bib-0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003735","article-title":"Sudden cardiac death in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial","volume":"5","author":"Eisen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026012114074666400_ehf212854-bib-0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191214","article-title":"Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records","volume":"13","author":"Pujades-Rodriguez","year":"2018","journal-title":"PLoS One"},{"key":"2026012114074666400_ehf212854-bib-0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10840-017-0308-9","article-title":"Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis","volume":"51","author":"Rattanawong","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"2026012114074666400_ehf212854-bib-0029","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"2026012114074666400_ehf212854-bib-0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.hjc.2017.11.012","article-title":"Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks","volume":"58","author":"Miyazawa","year":"2017","journal-title":"Hellenic J Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12854","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12854","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/6\/3601\/65901436\/eschf_7_6_3601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/6\/3601\/65901436\/eschf_7_6_3601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:08:26Z","timestamp":1769022506000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/6\/3601\/8372406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,9,17]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12854","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"2020-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}